SelectMDx improves prostate biopsy decision-making in urology practices
Go back to SelectMDx improves prostate biopsy decision-making in urology practices| (NASDAQ: MDXH) | Delayed: 0.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.21 | 52 Week High | $ | |||
| Open | $0.22 | 52 Week Low | $ | |||
| Day High | $0.22 | P/E | N/A | |||
| Day Low | $0.20 | EPS | $ | |||
| Volume | 367,050 | |||||



